Russell OM, Gorman GS, Lightowlers RN, Turnbull DM. Mitochondrial diseases: hope for the future. Cell. 2020;181:168–88.
Article CAS PubMed Google Scholar
Braunwald E. Mitochondrial cardiomyopathy: a fertile field for research. Eur Heart J. 2023;44:2361–2.
Morgan PG, Hoppel CL, Sedensky MM. Mitochondrial defects and anesthetic sensitivity. Anesthesiology. 2002;96:1268–70.
Wolf A, Weir P, Stone J, Shield J. Impaired fatty acid oxidation in propofol infusion syndrome. Lancet. 2001;357:606–7.
Article CAS PubMed Google Scholar
Niezgoda J, Morgan PG. Anesthetic considerations in patients with mitochondrial defect. Paediatr Anaesth. 2013;23:785–93.
Article PubMed PubMed Central Google Scholar
Kitaura A, Kosumi R, Iwamoto T, Nakao S. Remimazolam anesthesia for transcatheter mitral valve repair in a patient with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) syndrome: a case report. JA Clin Rep. 2022;8:38.
Article PubMed PubMed Central Google Scholar
Huruma T, Saji M, Nanasat M, Isobe M. Successful transcatheter mitral valve repair for functional mitral regurgitation in a patient with mitochondrial cardiomyopathy: a case report. Eur Heart J. 2023;7:ytad440.
Drissen J, Willems S, Dercksen S, Giele J, van der Staak F, Smeitink J. Anesthesia-related morbidity and mortality after surgery for muscle biopsy in children with mitochondrial defects. Paediatr Anaesth. 2007;17:16–21.
Hanley PJ, Ray J, Brandt U, Daut J. Halothane, isoflurane and sevoflurane inhibit NADH:ubiquinone oxidoreductase (complex I) of cardiac mitochondria. J Physiol. 2002;544:687–93.
Article CAS PubMed PubMed Central Google Scholar
Hirata N, Shim YH, Pravdic D, Lohr NL, Pratt PF Jr, Weihrauch D, et al. Isoflurane differentially modulates mitochondrial reactive oxygen species production via forward versus reverse electron transport flow: implications for preconditioning. Anesthesiology. 2011;115:531–40.
Article CAS PubMed Google Scholar
Bergamini C, Moruzzi N, Volta F, Faccioli L, Gerdes J, Mondardini MC, Fato R. Role of mitochondrial complex I and protective effect of CoQ10 supplementation in propofol induced cytotoxicity. J Bioenerg Biomembr. 2016;48:413–23.
Article CAS PubMed Google Scholar
Wu GJ, Tai YT, Chen TL, Lin LL, Ueng YF, Chen RM. Propofol specifically inhibits mitochondrial membrane potential but not complex I NADH dehydrogenase activity, thus reducing cellular ATP biosynthesis and migration of macrophages. Ann N Y Acad Sci. 2005;1042:168–76.
Article CAS PubMed Google Scholar
Hemphill S, McMenamin L, Bellamy MC, Hopkins PM. Propofol infusion syndrome: a structured literature review and analysis of published case reports. Br J Anaesth. 2019;122:448–59.
Article CAS PubMed PubMed Central Google Scholar
Uezono S, Hotta Y, Takakuwa Y, Ozaki M. Acquired carnitine deficiency: a clinical model for propofol infusion syndrome? Anesthesiology. 2005;103:909.
Savard M, Dupre N, Turgeon AF, Desbiens R, Langevin S, Brunet D. Propofol-related infusion syndrome heralding a mitochondrial disease: case report. Neurology. 2013;81:770–1.
Article PubMed PubMed Central Google Scholar
Vanlander AV, Jorens PG, Smet J, De Paepe B, Verbrugghe W, Van den Eynden GG, et al. Inborn oxidative phosphorylation defect as risk factor for propofol infusion syndrome. Acta Anaesthesiol Scand. 2012;56:520–5.
Article CAS PubMed Google Scholar
Colleoni M, Costa B, Gori E, Santagostino A. Biochemical characterization of the effects of the benzodiazepine, midazolam, on mitochondrial electron transfer. Pharmacol Toxicol. 1996;78:69–76.
Article CAS PubMed Google Scholar
Doi M, Morita K, Takeda J, Sakamoto A, Yamakage M, Suzuki T. Efficacy and safety of remimazolam versus propofol for general anesthesia: multicenter, single-blind, randomized, parallel-group, phase IIb/III trial. J Anesth. 2020;34:543–53.
Doi M, Hirata N, Suzuki T, Morisaki H, Morimatsu H, Sakamoto A. Safety and efficacy of remimazolam in induction and maintenance of general anesthesia in high-risk surgical patients (ASA Class III): results of a multicenter, randomized, double-blind, parallel-group comparative trial. J Anesth. 2020;34:491–501.
Yoshikawa Y, Oura S, Kanda M, Chaki T, Hirata N, Edanaga M, et al. Comparison of the negative effect of remimazolam and propofol on cardiac contractility: Analysis of a randomized parallel-group trial and a preclinical ex vivo study. Clin Exp Pharmacol Physiol. 2024;51:e13840.
Article CAS PubMed Google Scholar
Nam SW, Yim S, Choi CI, Park I, Joung KW, Song IA. Effects of remimazolam on hemodynamic changes during cardiac ablation for atrial fibrillation under general anesthesia: a propensity-score-matched retrospective cohort study. Can J Anaesth. 2023;70:1495–503.
Article CAS PubMed Google Scholar
Hasegawa G, Hirata N, Yoshikawa Y, Yamakage M. Differential effects of remimazolam and propofol on heart rate variability during anesthesia induction. J Anesth. 2022;36:239–45.
Hirata N. Remimazolam for cardiovascular anesthesia. J Anesth. 2023;37:825–7.
Satoh T, Nishihara N, Sawashita Y, Ohno S, Hirata N, Yamakage M. Remimazolam anesthesia for mitraclip implantation in a patient with advanced heart failure. Case Rep Anesthesiol. 2021;2021:5536442.
PubMed PubMed Central Google Scholar
Fujii E, Tanaka-Mizuno S, Fujino K, Fujii M, Furuno M, Sugimoto Y, et al. Dexmedetomidine attenuates the positive chronotropic effects of intravenous atropine in patients with bradycardia during spinal anesthesia: a retrospective study. JA Clin Rep. 2018;4:70.
Article PubMed PubMed Central Google Scholar
Sajima T, Onimaru T, Sawamura S. Temporary worsening of mitral regurgitation due to conduction disturbance after transcatheter aortic valve implantation. JA Clin Rep. 2021;7:87.
留言 (0)